Literature DB >> 31250012

Helicobacter pylori infection and the risk of colorectal cancer: a nationwide population-based cohort study.

I-L Liu1, C-H Tsai2, C-H Hsu3,4, J-M Hu3,5,6, Y-C Chen7,8, Y-F Tian9, S-L You7,8, C-Y Chen5,6, C-W Hsiao5, C-Y Lin10, Y-C Chou1,2, C-A Sun8,11.   

Abstract

BACKGROUND: The role of Helicobacter pylori (H. pylori) infection in the development of colorectal neoplasia has been a matter of scientific debate with controversial findings. AIMS: This study examined the association between H. pylori infection and colorectal cancer (CRC) in a nationwide population-based Chinese cohort study.
METHODS: A total of approximately 3936 individuals with newly diagnosed H. pylori infection (the H. pylori-infected cohort) and 15 744 age- and sex-matched patients with diagnoses absence of H. pylori infection (the comparison cohort) from 2000 to 2005 were identified from Taiwan's National Health Insurance Research Database. The Kaplan-Meier method was used for measuring the cumulative incidence of CRC in each cohort. Cox proportional hazards models were used to compute hazard ratios (HRs) and accompanying 95% confidence intervals (CIs) for the estimation of the association between H. pylori infection and CRC.
RESULTS: The cumulative incidence of CRC was higher in H. pylori-infected cohort than that in the comparison cohort (log-rank test, P < 0.001). After adjustment for potential confounders, H. pylori infection was associated with a significantly increased risk of CRC (adjusted HR 1.87; 95% CI 1.37-2.57). In addition, the HR of CRC appeared to increase with increasing frequency of clinical visits for H. pylori infection.
CONCLUSIONS: Our study demonstrated that H. pylori infection was associated with an increased risk of CRC, which warrants confirmation and exploration of the underlying biologic mechanisms by future studies.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 31250012     DOI: 10.1093/qjmed/hcz157

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  3 in total

Review 1.  Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer.

Authors:  Hua-Zhong Ying; Wei Xie; Meng-Chuan Wang; Jia-Qi He; Huan-Huan Zhang; Chen-Huan Yu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-16       Impact factor: 6.073

2.  Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan.

Authors:  Chia-Ming Liang; Chih-Hsiung Hsu; Chi-Hsiang Chung; Chao-Yang Chen; Lin-Yin Wang; Sheng-Der Hsu; Pi-Kai Chang; Zhi-Jie Hong; Wu-Chien Chien; Je-Ming Hu
Journal:  Int J Environ Res Public Health       Date:  2020-05-25       Impact factor: 3.390

3.  H. pylori Infection and Colorectal Cancers by Anatomical Locations.

Authors:  Dao Viet Hang; Dinh Thi Minh; Tran Hieu Hoc; Le Hong Phuoc; Tran Que Son; Ngoan Tran Le
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.